Literature DB >> 14720448

Pruritus in chronic liver disease: mechanisms and treatment.

Nora V Bergasa1.   

Abstract

Pruritus is a complication of liver disease. It can have a marked negative impact on quality of life; when intractable, it is an indication for liver transplantation. The cause of this type of pruritus is unknown. There is, however, evidence to suggest that the pruritus associated with liver disease is mediated, at least in part, by endogenous opioids. A central mechanism has been proposed. Therapeutic interventions have concentrated on the removal of presumed and unknown pruritogens from the circulation, hepatic enzyme induction, and, over the past decade, opiate antagonists, the first specific treatment for the pruritus of cholestasis. Other pharmacologic interventions that change neurotransmission have recently been reported to decrease the pruritus in patients with liver disease, as has a newly developed system that applies albumin-based dialysis. These interventions are promising, but they must be tested in properly controlled behavioral trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720448     DOI: 10.1007/s11894-004-0020-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  70 in total

1.  Gabapentin treatment for brachioradial pruritus.

Authors:  H A Bueller; J D Bernhard; L M Dubroff
Journal:  J Eur Acad Dermatol Venereol       Date:  1999-11       Impact factor: 6.166

2.  Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.

Authors:  N V Bergasa; D W Alling; T L Talbot; M C Wells; E A Jones
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

3.  Unilateral neurogenic pruritus following stroke.

Authors:  E W Massey
Journal:  Stroke       Date:  1984 Sep-Oct       Impact factor: 7.914

4.  Uptake and efflux of the peptidic delta-opioid receptor agonist.

Authors:  C Dagenais; J Ducharme; G M Pollack
Journal:  Neurosci Lett       Date:  2001-04-06       Impact factor: 3.046

5.  Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.

Authors:  M I Prince; A D Burt; D E J Jones
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

6.  The medullary dorsal horn: a target for the expression of opiate effects on the perceived intensity of noxious heat.

Authors:  J L Oliveras; W Maixner; R Dubner; M C Bushnell; D R Kenshalo; G H Duncan; D A Thomas; R Bates
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

7.  Efficacy and safety of long-term phenobarbital therapy of familial cholestasis.

Authors:  C N Ghent; J R Bloomer; Y E Hsia
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Central mu-opioid receptors are down-regulated in a rat model of cholestasis.

Authors:  N V Bergasa; R B Rothman; J Vergalla; H Xu; M G Swain; E A Jones
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

9.  The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis.

Authors:  Alan R Gingold; Nora V Bergasa
Journal:  Life Sci       Date:  2003-10-10       Impact factor: 5.037

10.  Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.

Authors:  Guy W Neff; Christopher B O'Brien; K Rajender Reddy; Nora V Bergasa; Arie Regev; Enrique Molina; Rafael Amaro; Miguel J Rodriguez; VeEtta Chase; Lennox Jeffers; Eugene Schiff
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  5 in total

Review 1.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

2.  Treatment of the Pruritus of Cholestasis.

Authors:  Nora V Bergasa
Journal:  Curr Treat Options Gastroenterol       Date:  2004-12

Review 3.  Role of supportive care for terminal stage hepatocellular carcinoma.

Authors:  Manoj Kumar; Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-03-31

4.  Pruritus in certain internal diseases.

Authors:  D Yonova
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

Review 5.  Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities.

Authors:  Nagihan Tarikci; Emek Kocatürk; Şule Güngör; Ilteriş Oğuz Topal; Pelin Ülkümen Can; Ralfi Singer
Journal:  ScientificWorldJournal       Date:  2015-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.